Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcin Braun

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Cancers|November 25, 2023
Leukemia Cutis-The Current View on Pathogenesis, Diagnosis, and TreatmentEwa Robak, Marcin Braun, Tadeusz Robak
Leukemia & Lymphoma|May 20, 2025
A current view of the pathogenesis and treatment of primary cutaneous diffuse large B cell lymphoma - leg typeEwa Robak, Marcin Braun, Tadeusz Robak
Endocrine Pathology|June 7, 2020
High Expression of NEK2 and PIM1, but Not PIM3, Is Linked to an Aggressive Phenotype of Bronchopulmonary Neuroendocrine NeoplasmsEwelina Motylewska, Marcin Braun, Henryk Stępień
Cancer Treatment Reviews|February 22, 2022
PARP inhibitors for metastatic castration-resistant prostate cancer: Biological rationale and current evidenceMichał Bieńkowski, Bartłomiej Tomasik, Marcin Braun, et al.
Annals of Hematology|July 25, 2024
Extramedullary and extranodal manifestations in chronic lymphocytic leukemia - an updateTadeusz Robak, Anna Puła, Marcin Braun, et al.
Cancer Cell|April 23, 2021
Targeting cell-cycle machinery in cancerJan M Suski, Marcin Braun, Vladislav Strmiska, et al.
International Journal of Oncology|September 2, 2024
FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review)Julia Solek, Marcin Braun, Rafal Sadej, et al.
British Journal of Cancer|April 16, 2024
FGFR4-driven plasticity in breast cancer progression and resistance to therapyMarcin Braun, Dominika Piasecka, Rafal Sadej, et al.
European Journal of Haematology|February 11, 2025
Atypical Hairy Cell Leukemia-The Current Status and Future DirectionsTadeusz Robak, Marta Robak, Agata Majchrzak, et al.
Frontiers in Oncology|September 29, 2025
FGFR2 expression relates to subtype-specific tumour microenvironment (TIME) during luminal breast cancer evolutionJulia Sołek, Aleksandra Zielińska, Radzisław Kordek, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Cancers|November 25, 2023
Leukemia Cutis-The Current View on Pathogenesis, Diagnosis, and TreatmentEwa Robak, Marcin Braun, Tadeusz Robak
Leukemia & Lymphoma|May 20, 2025
A current view of the pathogenesis and treatment of primary cutaneous diffuse large B cell lymphoma - leg typeEwa Robak, Marcin Braun, Tadeusz Robak
Endocrine Pathology|June 7, 2020
High Expression of NEK2 and PIM1, but Not PIM3, Is Linked to an Aggressive Phenotype of Bronchopulmonary Neuroendocrine NeoplasmsEwelina Motylewska, Marcin Braun, Henryk Stępień
Cancer Treatment Reviews|February 22, 2022
PARP inhibitors for metastatic castration-resistant prostate cancer: Biological rationale and current evidenceMichał Bieńkowski, Bartłomiej Tomasik, Marcin Braun, et al.
Annals of Hematology|July 25, 2024
Extramedullary and extranodal manifestations in chronic lymphocytic leukemia - an updateTadeusz Robak, Anna Puła, Marcin Braun, et al.
Cancer Cell|April 23, 2021
Targeting cell-cycle machinery in cancerJan M Suski, Marcin Braun, Vladislav Strmiska, et al.
International Journal of Oncology|September 2, 2024
FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review)Julia Solek, Marcin Braun, Rafal Sadej, et al.
British Journal of Cancer|April 16, 2024
FGFR4-driven plasticity in breast cancer progression and resistance to therapyMarcin Braun, Dominika Piasecka, Rafal Sadej, et al.
European Journal of Haematology|February 11, 2025
Atypical Hairy Cell Leukemia-The Current Status and Future DirectionsTadeusz Robak, Marta Robak, Agata Majchrzak, et al.
Frontiers in Oncology|September 29, 2025
FGFR2 expression relates to subtype-specific tumour microenvironment (TIME) during luminal breast cancer evolutionJulia Sołek, Aleksandra Zielińska, Radzisław Kordek, et al.
Pageof 11